Second generation CB1 receptor blockers and other inhibitors of peripheral endocannabinoid overactivity and the rationale of their use against metabolic disorders

Author： Silvestri Cristoforo   Di Marzo Vincenzo  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.21, Iss.9, 2012-09, pp. : 1309-1322

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A New Perspective of Cannabinoid 1 Receptor Antagonists: Approaches Toward Peripheral CB1R Blockers without Crossing the Blood-Brain Barrier

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 12, 2011-06 ,pp. : 1421-1429

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Development of CB2 Selective and Peripheral CB1/CB2 Cannabinoid Receptor Ligands

By  

Current Medicinal Chemistry, Vol. 21, Iss. 2, 2014-01 ,pp. : 187-203

Bentham Science Publishers

Access to resources Recommend Favorite

Design of Second Generation HIV-1 Integrase Inhibitors

By  

Current Pharmaceutical Design, Vol. 13, Iss. 2, 2007-01 ,pp. : 129-141

Bentham Science Publishers

Access to resources Recommend Favorite

The use of -blockers, ACE inhibitors/ angiotensin receptor blockers (ARBs), or a combination of both, is associated with decreased mortality among elderly inpatients with congestive heart failure

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 437, 2003-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

CB1 Cannabinoid Receptor Ligands

By  

Mini Reviews in Medicinal Chemistry, Vol. 5, Iss. 7, 2005-07 ,pp. : 631-640

Bentham Science Publishers

Access to resources Recommend Favorite